Invention Grant
- Patent Title: One or more HMOs for reducing or preventing fatigue and/or improving focus or concentration
-
Application No.: US16761164Application Date: 2018-11-02
-
Publication No.: US11541069B2Publication Date: 2023-01-03
- Inventor: Bruce McConnell , Louise Kristine Vigsnæs , Ingvild Dybdrodt Amundsen
- Applicant: Glycom A/S
- Applicant Address: DK Hørsholm
- Assignee: Glycom A/S
- Current Assignee: Glycom A/S
- Current Assignee Address: DK Hørsholm
- Agency: Kunzler Bean & Adamson
- Agent Tom Briscoe
- Priority: DKPA201700616 20171102,DKPA201700679 20171130,DKPA201800293 20180625,WOPCT/IB2018/056308 20180821
- International Application: PCT/IB2018/058611 WO 20181102
- International Announcement: WO2019/087140 WO 20190509
- Main IPC: A61K31/702
- IPC: A61K31/702 ; A23L33/125
Abstract:
The invention relates to a human milk oligosaccharide (HMO) for use in reducing or preventing fatigue and/or improving focus or concentration on a mental or physical activity in a human. The invention also relates to a synthetic composition for use, comprising one or more of said HMOs. The invention further relates to a method for reducing or preventing fatigue and/or improving focus or concentration on a mental or physical activity by administering at least one HMO and the use of said one or more HMOs in a dietary management of a human.
Public/Granted literature
- US20200338100A1 ONE OR MORE HMOS FOR REDUCING OR PREVENTING FATIGUE AND/OR IMPROVING FOCUS OR CONCENTRATION Public/Granted day:2020-10-29
Information query
